Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Nostocyclopeptide-M1: a potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and OATP1B1.

Herfindal L, Myhren L, Kleppe R, Krakstad C, Selheim F, Jokela J, Sivonen K, Døskeland SO.

Mol Pharm. 2011 Apr 4;8(2):360-7. doi: 10.1021/mp1002224. Epub 2011 Jan 24.

PMID:
21214185
2.

Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.

Herfindal L, Krakstad C, Myhren L, Hagland H, Kopperud R, Teigen K, Schwede F, Kleppe R, Døskeland SO.

PLoS One. 2014 Apr 16;9(4):e94926. doi: 10.1371/journal.pone.0094926. eCollection 2014.

3.

Selectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cells.

Niedermeyer TH, Daily A, Swiatecka-Hagenbruch M, Moscow JA.

PLoS One. 2014 Mar 10;9(3):e91476. doi: 10.1371/journal.pone.0091476. eCollection 2014.

4.
5.

Inhibition of hepatic uptake transporters by flavonoids.

Mandery K, Balk B, Bujok K, Schmidt I, Fromm MF, Glaeser H.

Eur J Pharm Sci. 2012 May 12;46(1-2):79-85. doi: 10.1016/j.ejps.2012.02.014. Epub 2012 Feb 28.

PMID:
22394605
6.
7.

Rapid isolation of peptidic inhibitors of the solute carrier family transporters OATP1B1 and OATP1B3 by cell-based phage display selections.

Arita Y, Allen S, Chen G, Zhang W, Wang Y, Owen AJ, Dentinger P, Sidhu SS.

Biochem Biophys Res Commun. 2016 Apr 29;473(2):370-6. doi: 10.1016/j.bbrc.2016.01.050. Epub 2016 Jan 11.

PMID:
26792727
8.

Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.

Kunze A, Huwyler J, Camenisch G, Poller B.

Drug Metab Dispos. 2014 Sep;42(9):1514-21. doi: 10.1124/dmd.114.058412. Epub 2014 Jul 2.

9.

Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.

Gozalpour E, Greupink R, Wortelboer HM, Bilos A, Schreurs M, Russel FG, Koenderink JB.

Mol Pharm. 2014 Jun 2;11(6):1844-55. doi: 10.1021/mp400699p. Epub 2014 May 6.

PMID:
24754247
10.

Microcystin LR Shows Cytotoxic Activity Against Pancreatic Cancer Cells Expressing the Membrane OATP1B1 and OATP1B3 Transporters.

Kounnis V, Chondrogiannis G, Mantzaris MD, Tzakos AG, Fokas D, Papanikolaou NA, Galani V, Sainis I, Briasoulis E.

Anticancer Res. 2015 Nov;35(11):5857-65.

PMID:
26504008
11.

Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.

Jeong HU, Kwon M, Lee Y, Yoo JS, Shin DH, Song IS, Lee HS.

Drug Des Devel Ther. 2015 Jan 22;9:643-53. doi: 10.2147/DDDT.S75400. eCollection 2015.

12.

Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).

Roth M, Araya JJ, Timmermann BN, Hagenbuch B.

J Pharmacol Exp Ther. 2011 Nov;339(2):624-32. doi: 10.1124/jpet.111.184564. Epub 2011 Aug 16.

13.

Okadaic acid is taken-up into the cells mediated by human hepatocytes transporter OATP1B3.

Ikema S, Takumi S, Maeda Y, Kurimoto T, Bohda S, Chigwechokha PK, Sugiyama Y, Shiozaki K, Furukawa T, Komatsu M.

Food Chem Toxicol. 2015 Sep;83:229-36. doi: 10.1016/j.fct.2015.06.006. Epub 2015 Jun 29.

PMID:
26134461
14.

Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.

Bednarczyk D.

Anal Biochem. 2010 Oct 1;405(1):50-8. doi: 10.1016/j.ab.2010.06.012. Epub 2010 Jun 9.

15.

Involvement of mitogen-activated protein kinase signaling pathways in microcystin-LR-induced apoptosis after its selective uptake mediated by OATP1B1 and OATP1B3.

Komatsu M, Furukawa T, Ikeda R, Takumi S, Nong Q, Aoyama K, Akiyama S, Keppler D, Takeuchi T.

Toxicol Sci. 2007 Jun;97(2):407-16. Epub 2007 Mar 16.

PMID:
17369605
16.

Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.

Shitara Y, Takeuchi K, Nagamatsu Y, Wada S, Sugiyama Y, Horie T.

Drug Metab Pharmacokinet. 2012;27(4):368-78. Epub 2012 Jan 13.

17.

Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes.

Yamaguchi H, Takeuchi T, Okada M, Kobayashi M, Unno M, Abe T, Goto J, Hishinuma T, Shimada M, Mano N.

Biol Pharm Bull. 2011;34(3):389-95.

18.

Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.

Visentin M, Stieger B, Merz M, Kullak-Ublick GA.

J Pharmacol Exp Ther. 2015 Nov;355(2):145-51. doi: 10.1124/jpet.115.227546. Epub 2015 Sep 1.

19.
20.

Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.

Durmus S, Lozano-Mena G, van Esch A, Wagenaar E, van Tellingen O, Schinkel AH.

Mol Pharm. 2015 Dec 7;12(12):4259-69. doi: 10.1021/acs.molpharmaceut.5b00453. Epub 2015 Oct 29.

PMID:
26474710

Supplemental Content

Support Center